Medical Device News Magazine

Dr Fred Cohen: Higher Temperatures Trigger Migraines According to New Study

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

It is only the first full week of summer, and a record-breaking heatwave is already sending temperatures soaring to dangerously high levels in the Northeast and Midwest, with much of the U.S. suffering through sweltering humidity. One medical researcher is cautioning people to watch for headache and migraine attacks as a result. Specifically, Dr Fred Cohen, Assistant Professor of Medicine and Neurology at the Icahn School of Medicine at Mount Sinai in New York, recently co-authored a new headache study that he presented at the American Headache Society’s 66th Annual Scientific Meeting in San Diego, CA, which demonstrates a relationship between weather variables and headache attacks in individuals with migraines.

The Annual Scientific Meeting is designed for physicians, psychologists, scientists, researchers, physician assistants, nurse practitioners, and other health professionals involved in the care of patients with head, neck, and orofacial pain.

“Many triggers are associated with headaches and migraines, but weather changes are among the most commonly reported; however, data and metrics on these weather changes have rarely been published until now,” said Dr. Cohen. “Our groundbreaking study finds that increased temperature, humidity, and barometric pressure typically intensifies headache attacks in the 40 million Americans who suffer from migraines.”

In the study, researchers examined 71,030 daily diary records from 660 migraine patients and correlated them with regional weather data. They discovered that for each 10-degree Fahrenheit rise in daily temperature, there was a 6% increase in headache occurrences.

Dr Fred Cohen notes that there is hope on the horizon as the study also indicates that patients who were treated with Fremanezumab (Ajovy®), a calcitonin gene-related peptide (CGRP) monoclonal antibody treatment approved by the FDA for migraine prevention, improved these weather-related headaches.

“This study is the first to suggest that migraine-specific therapies that block CGRP may treat weather associated headaches,” adds Dr. Cohen. “It’s quite remarkable that, despite the diverse weather patterns nationwide, we were able to identify such a significant influence. It also raises concerns about greater weather variability and more frequent severe weather events and their relationship with migraines, especially as climate change progresses.”

Another keynote theme of the conference was the use of artificial intelligence (AI) in headache diagnosis, management, and detecting migraine comorbidities. Dr. Cohen gave a lecture on the use of large language models (LLMs), such as ChatGPT and CoPilot, in clinical practice and their potential to improve provider efficiency. Other emerging topics included new acute treatments for migraine, such as vaporized cannabis and novel targets like transient receptor potential melastatin 3 (TRPM3) and pituitary adenylate cyclase-activating polypeptide (PACAP).

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”